Common use of Investigator Obligations Clause in Contracts

Investigator Obligations. Investigator will devote his/her best efforts to accurately and efficiently perform the work required under this Agreement, which efforts shall include but are not limited to the following: (i) exercise of independent medical judgment as to the compatibility of each Study patient with the Protocol requirements; (ii) notification of Labcorp and Sponsor, if required of any deviations from or failure to comply with the Protocol; (iii) promptly replying to any questions from Labcorp or Sponsor regarding any matter related to the Study; (iv) promptly notifying Labcorp of any significant changes that occur at any time during the Study which may affect Investigator or Institution’s ability to conduct the Study, including but not limited to, changes in personnel involved in the Study (v) record and document all Adverse Events and laboratory abnormalities identified in the Protocol as critical to the safety evaluation; (vi) report all Serious Adverse Events to Labcorp and/or the Sponsor without undue delay but not later than within twenty-four (24) hours of obtaining knowledge of the events, unless, for certain Serious Adverse Events, the Protocol provides that no immediate reporting is required. (c)

Investigator Obligations. Investigator will devote his/her best efforts to accurately and efficiently perform the work required under this Agreement, which efforts shall include but are not limited to the following: (i) exercise i)exercise of independent medical judgment as to the compatibility of each Study patient with the Protocol requirements; (ii) notification ii)notification of Labcorp Covance and Sponsor, if required of any deviations from or failure to comply with the Protocol; (iii) promptly iii)promptly replying to any questions from Labcorp Covance or Sponsor regarding any matter related to the Study; (iv) promptly iv)promptly notifying Labcorp Covance of any significant changes that occur at any time during the Study which may affect Investigator or Institution’s ability to conduct the Study, including but not limited to, changes in personnel involved in the Study (v) record v)record and document all Adverse Events and laboratory abnormalities identified in the Protocol as critical to the safety evaluation; (vi) report vi)report all Serious Adverse Events to Labcorp Covance and/or the Sponsor without undue delay but not later than within twenty-four (24) hours of obtaining knowledge of the events, unless, for certain Serious Adverse Events, the Protocol provides that no immediate reporting is required. (c)

Investigator Obligations. Investigator will devote his/her best efforts to accurately and efficiently perform the work required under this Agreement, which efforts shall include but are not limited to the following: (i) exercise of independent medical judgment as to the compatibility of each Study patient with the Protocol requirements; (ii) notification of Labcorp Covance and Sponsor, if required of any deviations from or failure to comply with the Protocol; (iii) promptly replying to any questions from Labcorp Covance or Sponsor regarding any matter related to the Study; (iv) promptly notifying Labcorp Covance of any significant changes that occur at any time during the Study which may affect Investigator or Institution’s ability to conduct the Study, including but not limited to, changes in personnel involved in the Study (v) record and document all Adverse Events and laboratory abnormalities identified in the Protocol as critical to the safety evaluation; (vi) report all Serious Adverse Events to Labcorp Covance and/or the Sponsor without undue delay but not later than within twenty-four (24) hours of obtaining knowledge of the events, unless, for certain Serious Adverse Events, the Protocol provides that no immediate reporting is required. (c)

Investigator Obligations. Investigator will devote his/her best efforts to accurately and efficiently perform the work required under this Agreement, which efforts shall include but are not limited to the following: (i) exercise i)exercise of independent medical judgment as to the compatibility of each Study patient with the Protocol requirements; (ii) notification ii)notification of Labcorp Covance and Sponsor, if required of any deviations from or failure to comply with the Protocol; (iii) promptly replying iii)without delayreplying to any questions from Labcorp Covance or Sponsor regarding any matter related to the Study; (iv) promptly iv)without delay notifying Labcorp Covance of any significant changes that occur at any time during the Study which may affect Investigator or Institution’s ability to conduct the Study, including but not limited to, changes in personnel involved in the Study (v) record v)record and document all Adverse Events and laboratory abnormalities identified in the Protocol as critical to the safety evaluation; (vi) report vi)report all Serious Adverse Events to Labcorp Covance and/or the Sponsor without undue delay but not later than within twenty-four (24) hours of obtaining knowledge of the events, unless, for certain Serious Adverse Events, the Protocol provides that no immediate reporting is required. (c)